Navigation Links
Leading Global Clinical Research Organization chooses GBS to Support their IBM Domino Infrastructure
Date:7/29/2013

Woodstock, GA (PRWEB) July 29, 2013

GBS Enterprises Inc. (GBSX), a global software and services company specializing in Application Modernization, Mobility and Infrastructure Management announced that they have been chosen to support and maintain the IBM Domino and Notes infrastructure of one of the world’s leading clinical research firms.

The firm is known for its high performance and reputation for conducting global clinical development programs of the highest integrity. It is a leader in delivering clinical trial programs to pharmaceutical and biotechnology companies in therapeutic areas of specialty, and in innovative pediatric and women’s health trials.

With an increase in demand on critical IT resources it was an easy decision to choose GBS to manage their IBM Domino and Notes infrastructure.

“Organizations with IBM Notes and Domino infrastructure continue to have increased demand from users for improved infrastructure and support systems. Having internal IT staff spend time maintaining and supporting existing infrastructure is expensive, and as we are also hearing from many customers, prevents them from focusing on strategic and long term projects”, says Joerg Ott, CEO of GBS. “GBS’ Domino Admin Services offerings are tailored specifically for organizations running IBM Domino infrastructure to enable them to reduce cost, optimize performance and improve SLAs.”    

About GBS (GROUP Business Software)
GBS Enterprises Inc. (GBSX) is the world’s leading provider of expertise and solutions for the IBM Notes and Domino platform. GBS enables organizations with investments in Notes and Domino infrastructure to effectively respond to the rapidly evolving needs of their business users, while lowering costs and increasing returns on these investments. GBS helps customers understand and evaluate their cur-rent infrastructure and application environments, formulate strategic technology and operational goals, and implement solutions that meet current and future business needs.

GBS has over 5,000 customers with over 4 million users of its products and services. GBS resources are available at 12 locations across North America, Europe and Asia. For more information, please visit http://www.gbs.com.

Caution Concerning Forward-Looking Statements
This release contains statements that may constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. These statements regard the intent, belief, and expectations of the Company. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, they involve risks and uncertainties, and their results may differ materially.

Media Contact:
Michael Baum, Corporate Communications
michael(dot)baum(at)us(dot)gbs(dot)com

Read the full story at http://www.prweb.com/releases/2013/7/prweb10971777.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
2. Diabetes drug could treat leading cause of blindness
3. Pneumonia and preterm birth complications are the leading causes of childhood death
4. Leading health care quality expert is 2012 AcademyHealth Distinguished Investigator
5. Dr. Edmund Lipskis & Dr. Lynn Lipskis Will be Featured On New National Television Show Entitled: “Leading The Field” World Class Experts Share Their Tips & Advice
6. ACR: Medical imaging study in health affairs incomplete and potentially misleading
7. Poorly-performing hand implants unacceptable says leading medical journal
8. Leading cancer specialists from Europe and beyond recognized at ESMO 2012
9. WSU researchers discover mechanism leading from trichomoniasis to prostate cancer
10. Report: Cancer now leading cause of death in US hispanics
11. Leading stem cell scientists to focus on diabetes, eye diseases at Cedars-Sinai symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: